White Paper

Successful Industrialization Requires Solid Foundations

By Jennifer Riter, Senior Director, Business and Technical Operations, and Victoria Morgan, Director, Biologics Marketing, West Pharmaceutical Services, Inc.


The increased complexity and cost associated with manufacturing innovative therapeutics—compounded by the increased scrutiny from regulatory authorities on the supply chain’s ability to deliver even greater levels of quality—are requiring containment system and drug delivery system manufacturers to develop components that not only ensure quality, safety, and efficacy throughout a drug product’s lifecycle, but also mitigate the risks and maximize the efficiencies of fill-finish processing.

Learn how choosing the appropriate quality of containment systems from the outset is critical to the successful industrialisation of an injectable drug product and review some of the challenges associated with injectables – most notably extractables, leachables and particulates – which are some of the primary reasons for a product recall.

access the White Paper!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Med Device Online? Subscribe today.

Subscribe to Med Device Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Med Device Online

West Pharmaceutical Services, Inc.